BamSEC and AlphaSense Join Forces
Learn More

Alnylam Pharmaceuticals Inc. – Indentures

NASDAQ: ALNY    
Share price (8/10/26): $216.98    
Market cap (8/10/26): $29.0 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 126 pages Alnylam Pharmaceuticals, Inc. and the Bank of New York Mellon, as Trustee Indenture Dated as of September 12, 2025 0.00% Convertible Senior Notes Due 2028
12/34/56
EX-4.1
from 10-Q 123 pages Alnylam Pharmaceuticals, Inc. and the Bank of New York Mellon, as Trustee Indenture Dated as of September 15, 2022 1.00% Convertible Senior Notes Due 2027
12/34/56
EX-4.1
from 8-K 123 pages Alnylam Pharmaceuticals, Inc. and the Bank of New York Mellon, as Trustee Indenture Dated as of September 15, 2022 1.00% Convertible Senior Notes Due 2027
12/34/56
EX-4.2
from S-3ASR 37 pages Stock Purchase Agreement by and Among the Investors Listed Herein and Alnylam Pharmaceuticals, Inc. Dated as of April 10, 2020
12/34/56
EX-4.2
from 10-K 4 pages Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.1
from S-3ASR 39 pages Alnylam Pharmaceuticals, Inc. Issuer and [ ], Trustee Indenture Dated as of [ ], 201[ ] Senior Debt Securities
12/34/56
EX-4.1
from 8-K 3 pages Certificate of Elimination of the Series a Junior Participating Preferred Stock of Alnylam Pharmaceuticals, Inc. Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware
12/34/56
EX-4.1
from 8-K 6 pages First Amendment to Rights Agreement
12/34/56
EX-4.4
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 59 pages Alnylam Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 54 pages Alnylam Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.4
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3 59 pages Alnylam Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 55 pages Alnylam Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-K ~50 pages Ex-4.1 Rights Agreement
12/34/56
EX-4
from SC 13D 7 pages First Amendment to Registration Rights Agreement
12/34/56
EX-4.1
from S-1/A 1 page Ex-4.1 Specimen Certificate
12/34/56
EX-4.1
from S-1/A 1 page Ex-4.1 Specimen Certificate Evidencing Shares
12/34/56